Scintigraphic Improvement of Primary Intestinal Lymphangiectasia in a Patient Treated With Alpelisib for a PIK3CA-Related Overgrowth Spectrum
Source: Clinical Nuclear Medicine
Hyperglycemic hyperosmolar coma induced by alpelisib in PIK3CA-related overgrowth spectrum (PROS)
Source: Annales de Dermatologie et de Venereologie
Genotyping as Part of Routine Clinical Care—The Outcomes for a Large Paediatric Vascular Anomaly Cohort
Source: American Journal of Medical Genetics, Part A
Genetic basis and imaging findings of neurofibromatosis 1 and other somatic overgrowth disorders
Source: Skeletal Radiology
Expanding the phenotypic spectrum of PROS: Reclassifying isolated lateralised overgrowth
Source: Journal of Medical Genetics
For Patient Families
To support patients and caregivers, Elsevier Health is making the latest research on these rare disorders available upon request at no cost.
Learn More
Note:
User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2025 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
